Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status
Top Cited Papers
- 28 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 105 (11), 823-832
- https://doi.org/10.1093/jnci/djt065
Abstract
The relationship between racial and socioeconomic status (SES) disparities and the quality of epithelial ovarian cancer care and survival outcome are unclear. A population-based analysis of National Cancer Data Base (NCDB) records for invasive primary epithelial ovarian cancer diagnosed in the period from 1998 to 2002 was done using data from patients classified as white or black. Adherence to National Comprehensive Cancer Network (NCCN) guideline care was defined by stage-appropriate surgical procedures and recommended chemotherapy. The main outcome measures were differences in adherence to NCCN guidelines and overall survival according to race and SES and were analyzed using binomial logistic regression and multilevel survival analysis. A total of 47 160 patients (white = 43 995; black = 3165) were identified. Non-NCCN-guideline-adherent care was an independent predictor of inferior overall survival (hazard ratio [HR] = 1.43, 95% confidence interval [CI] = 1.38 to 1.47). Demographic characteristics independently associated with a higher likelihood of not receiving NCCN guideline-adherent care were black race (odds ratio [OR] = 1.36, 95% CI = 1.25 to 1.48), Medicare payer status (OR = 1.20, 95% CI = 1.12 to 1.28), and not insured payer status (OR = 1.33, 95% CI = 1.19 to 1.49). After controlling for disease and treatment-related variables, independent racial and SES predictors of survival were black race (HR = 1.29, 95% CI = 1.22 to 1.36), Medicaid payer status (HR = 1.29, 95% CI = 1.20 to 1.38), not insured payer status (HR = 1.32, 95% CI = 1.20 to 1.44), and median household income less than $35 000 (HR = 1.06, 95% CI = 1.02 to 1.11). These data highlight statistically and clinically significant disparities in the quality of ovarian cancer care and overall survival, independent of NCCN guidelines, along racial and SES parameters. Increased efforts are needed to more precisely define the patient, provider, health-care system, and societal factors leading to these observed disparities and guide targeted interventions.Keywords
This publication has 36 references indexed in Scilit:
- Disparities in hospice care among older women dying with ovarian cancerGynecologic Oncology, 2012
- Have racial disparities in ovarian cancer increased over time? An analysis of SEER dataGynecologic Oncology, 2012
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian CancerJama-Journal Of The American Medical Association, 2011
- Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: A fundamental cause of disease approachSocial Science & Medicine (1982), 2010
- The National Cancer Data Base: Past, Present, and FutureAnnals of Surgical Oncology, 2009
- Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxelCancer, 2009
- Race in ovarian cancer treatment and survival: a systematic review with meta-analysisCancer Causes & Control, 2009
- Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancerGynecologic Oncology, 2008
- Patterns of Chemotherapy Use for Women With Ovarian Cancer: A Population-Based StudyJournal of Clinical Oncology, 2003
- Ovarian cancer: an institutional review of patterns of care, health insurance and prognosisEuropean Journal of Cancer, 2000